# NRX Pharmaceuticals, Inc.: Form 8-K, filed Sep 26, 2025

- Company: [NRX Pharmaceuticals, Inc.](/companies/nrxp.md) (CIK 1719406)
- Form: 8-K
- Filed: 2025-09-26
- Accepted by EDGAR: Sep 26, 2025, 08:01 ET
- Period: 2025-09-24
- Accession: 0001437749-25-029907
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1719406/000143774925029907/nrxp20250926_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1719406/000143774925029907/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1719406/000143774925029907/nrxp20250926_8k.htm

Filed Sep 26, 2025.
Source: SEC EDGAR, the filing index for accession 0001437749-25-029907. Last ingested by Listed: Nov 4, 2026, 20:02 ET. No prices; not investment advice.